Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683579 · ClinicalTrials.gov registry record
Neurocognitive Assessment in Youth Initiating HAART
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 220
- Enrollment target
NCT00683579 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 220 participants.
The verdict
NCT00683579 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
ATN 071 is a prospective cohort study comparing neurocognitive functioning in four groups of youth, age 18-24: Two groups with CD4+ T cells above 350 cells/mm3 and HIV RNA \>1,000 copies/ml, one initiating HAART (Group 1) and the other not initiating treatment (Group 2); and two groups with CD4+ T cells \< 350 cells/mm3, one initiating treatment (Group 3) and the other not initiating treatment (Group 4). Groups 2 and 3 represent standard of care. Group 1 and a portion of group 2 will be co-enrolled in ATN 061 and will be randomly assigned to group by that protocol.
Interventions
- OTHER No treatment
- DRUG Early Treatment with HAART
- DRUG HAART Treatment - standard care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683579
The ClinicalTrials.gov registry entry for NCT00683579 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which No treatment is the first listed.
NCT00683579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00683579 about?
NCT00683579 is a clinical study titled "Neurocognitive Assessment in Youth Initiating HAART". ATN 071 is a prospective cohort study comparing neurocognitive functioning in four groups of youth, age 18-24: Two groups with CD4+ T cells above 350 cells/mm3 and HIV RNA \>1,000 copies/ml, one initiating HAART (Group 1) and the other not initiating treatment (Group 2); and two groups with CD4+ T c...
What is the current status of trial NCT00683579?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2007-12. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00683579?
The interventions under investigation include: No treatment (OTHER), Early Treatment with HAART (DRUG), HAART Treatment - standard care (DRUG).
Who is sponsoring clinical trial NCT00683579?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.